[KROS] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
13-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 9.54%
YoY- -277.04%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 37 0 100 100 2,500 2,500 -56.90%
PBT -45,257 -37,505 -27,266 -15,622 -10,757 -2,853 73.70%
Tax 0 3,832 -3,462 -79 1 2 -
NP -45,257 -37,505 -23,804 -15,622 -10,757 -2,853 73.70%
Tax Rate - - - - - - -
Total Cost 45,294 37,505 23,904 15,722 13,257 5,353 53.20%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin -122,316.22 0.00 -23,804.00 -15,622.00 -430.28 -114.12 303.05%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -1.25 -1.27 -0.99 -0.67 -0.61 -0.32 31.28%
EPS Diluted -1.25 -1.27 -0.99 -0.67 -0.61 -0.32 31.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.